A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease.
about
Gene silencing: a therapeutic approach to combat influenza virus infections.Newer influenza antivirals, biotherapeutics and combinations.A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNAUnfolding of in planta activity of anti-rep ribozyme in presence of a RNA silencing suppressor.Specific temperature-induced perturbations of secondary mRNA structures are associated with the cold-adapted temperature-sensitive phenotype of influenza A virus.
P2860
A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A novel ribozyme-based prophyl ...... protects from severe disease.
@ast
A novel ribozyme-based prophyl ...... protects from severe disease.
@en
A novel ribozyme-based prophyl ...... protects from severe disease.
@nl
type
label
A novel ribozyme-based prophyl ...... protects from severe disease.
@ast
A novel ribozyme-based prophyl ...... protects from severe disease.
@en
A novel ribozyme-based prophyl ...... protects from severe disease.
@nl
prefLabel
A novel ribozyme-based prophyl ...... protects from severe disease.
@ast
A novel ribozyme-based prophyl ...... protects from severe disease.
@en
A novel ribozyme-based prophyl ...... protects from severe disease.
@nl
P2093
P2860
P1433
P1476
A novel ribozyme-based prophyl ...... protects from severe disease.
@en
P2093
Alexandra Paun
Jean-Pierre Perreault
Julie Motard
Martin Bisaillon
Veronika von Messling
P2860
P304
P356
10.1371/JOURNAL.PONE.0027327
P407
P50
P577
2011-11-14T00:00:00Z